ZNTL
NASDAQ · Biotechnology
Zentalis Pharmaceuticals Inc
$4.41
+0.18 (+4.26%)
Open$4.26
Previous Close$4.23
Day High$4.44
Day Low$4.20
52W High$6.95
52W Low$1.13
Volume—
Avg Volume896.0K
Market Cap288.30M
P/E Ratio—
EPS$-1.91
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+514.3% upside
Current
$4.41
$4.41
Target
$27.09
$27.09
$17.95
$27.09 avg
$27.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 72.61M | 27.61M | 25.42M |
| Net Income | -178,578,310 | -2,223,610 | -1,538,415 |
| Profit Margin | -246.0% | -8.1% | -6.1% |
| EBITDA | -204,495,165 | -3,072,165 | -2,609,903 |
| Free Cash Flow | — | -1,433,660 | -1,157,693 |
| Rev Growth | — | +21.3% | +16.0% |
| Debt/Equity | — | 0.13 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |